» Articles » PMID: 35966788

Enhanced Hippocampal Neurogenesis Mediated by PGC-1α-activated OXPHOS After Neonatal Low-dose Propofol Exposure

Overview
Specialty Geriatrics
Date 2022 Aug 15
PMID 35966788
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Developing brain is highly plastic and can be easily affected. Growing pediatric usage of anesthetics during painless procedures has raised concerns about the effect of low-dose anesthetics on neurodevelopment. It is urgent to ascertain the neuronal effect of low-dose Propofol, a widely used anesthetic in pediatrics, on developing brains.

Methods: The behavioral tests after neonatal exposure to low-dose/high-dose Propofol in mice were conducted to clarify the cognitive effect. The nascent cells undergoing proliferation and differentiation stage in the hippocampus and cultured neural stem cells (NSCs) were further identified. In addition, single-nuclei RNA sequencing (snRNA-seq), NSCs bulk RNA-seq, and metabolism trials were performed for pathway investigation. Furthermore, small interfering RNA and stereotactic adenovirus injection were, respectively, used in NSCs and hippocampal to confirm the underlying mechanism.

Results: Behavioral tests in mice showed enhanced spatial cognitive ability after being exposed to low-dose Propofol. Activated neurogenesis was observed both in hippocampal and cultured NSCs. Moreover, transcriptome analysis of snRNA-seq, bulk RNA-seq, and metabolism trials revealed a significantly enhanced oxidative phosphorylation (OXPHOS) level in NSCs. Furthermore, PGC-1α, a master regulator in mitochondria metabolism, was found upregulated after Propofol exposure both and . Importantly, downregulation of PGC-1α remarkably prevented the effects of low-dose Propofol in activating OXPHOS and neurogenesis.

Conclusions: Taken together, this study demonstrates a novel alteration of mitochondrial function in hippocampal neurogenesis after low-dose Propofol exposure, suggesting the safety, even potentially beneficial effect, of low-dose Propofol in pediatric use.

Citing Articles

The Long-Term Neuroprotective Effect of the Endocannabinoid 2-AG and Modulation of the SGZ's Neurogenic Response after Neonatal Hypoxia-Ischemia.

Beldarrain G, Hilario E, Lara-Celador I, Chillida M, Catalan A, Alvarez-Diaz A Pharmaceutics. 2023; 15(6).

PMID: 37376115 PMC: 10300731. DOI: 10.3390/pharmaceutics15061667.

References
1.
McMeekin L, Fox S, Boas S, Cowell R . Dysregulation of PGC-1α-Dependent Transcriptional Programs in Neurological and Developmental Disorders: Therapeutic Challenges and Opportunities. Cells. 2021; 10(2). PMC: 7915819. DOI: 10.3390/cells10020352. View

2.
Finck B, Kelly D . Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation. 2007; 115(19):2540-8. DOI: 10.1161/CIRCULATIONAHA.107.670588. View

3.
Deyama S, Duman R . Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Pharmacol Biochem Behav. 2019; 188:172837. PMC: 6997025. DOI: 10.1016/j.pbb.2019.172837. View

4.
Gao Y, Zhang R, Wei G, Dai S, Zhang X, Yang W . Long Non-coding RNA Maternally Expressed 3 Increases the Expression of Neuron-Specific Genes by Targeting miR-128-3p in All-Trans Retinoic Acid-Induced Neurogenic Differentiation From Amniotic Epithelial Cells. Front Cell Dev Biol. 2020; 7:342. PMC: 6936004. DOI: 10.3389/fcell.2019.00342. View

5.
Chen H, Xu D, Zhang Y, Yan Y, Liu J, Liu C . Neurons in the Locus Coeruleus Modulate the Hedonic Effects of Sub-Anesthetic Dose of Propofol. Front Neurosci. 2021; 15:636901. PMC: 7985178. DOI: 10.3389/fnins.2021.636901. View